| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b3e3de86fb3a7d008414342c8035051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b72691b61448140b9a080282c2ccf0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-13 |
| filingDate |
2020-01-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1768c6a3b47ca380745b601f25faa9e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4407720a9f14cca96e1b5e119f6b998a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39592a4f359ce83a1b7fc66603b79b32 |
| publicationDate |
2021-08-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210096462-A |
| titleOfInvention |
Composition for preventing or treating cancer comprising RNA particles containing siRNA for inhibiting USE1, and manufacturing method thereof |
| abstract |
The present invention relates to a composition for preventing or treating cancer containing an RNA particle containing siRNA that inhibits USE1 expression as an active ingredient and a method for preparing the same, wherein the RNA particle according to the present invention is cleaved by a specific Dicer for efficient siRNA release As bubbled RNA-based cargoes (BRCs) composed of sites, which consist of RNAi targeting USE1, it has a tumor growth inhibitory effect and can be used in cancer treatment. |
| priorityDate |
2020-01-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |